Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and isotretinoin

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with isotretinoin in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(isotretinoin)		Trials
(isotretinoin)		Recent Studies (post-2010) (isotretinoin)
791164,0645061,216

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)isotretinoin (IC50)
Adenosine receptor A3Homo sapiens (human)4.169
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)4.169
Alpha-2B adrenergic receptorHomo sapiens (human)6.612
Mitogen-activated protein kinase 1Homo sapiens (human)0.462
Cellular retinoic acid-binding protein 1Gallus gallus (chicken)0.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.848
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)4.169
Mitogen-activated protein kinase 14Homo sapiens (human)2.529
Olfactory receptor 51E2Homo sapiens (human)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and isotretinoin

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012